FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

(NYSE:JNJ) announced today that the FDA granted priority review to a new drug application (NDA) for its TAR-200.

The FDA prioritizes TAR-200 for treating high-risk bladder cancer, showcasing promising phase 2b study results and innovative ...

Johnson & Johnson (JNJ) gets FDA priority review for TAR-200 gains, a drug releasing system targeting bladder cancer. Read ...

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

Teen goes viral after bringing 200 tortillas on Texas flight When H-E-B heard about the teen's TikTok, the company chimed in: “Gotta keep those in the carry on. Don’t want to chance them ...

YouTube Shorts now averages 200 billion daily views, CEO Neal Mohan announced during his keynote at Cannes Lions 2025.

In a surprising twist, TaylorMade is releasing limited quantities of its MG Proto wedge. Here's what you need to.

ChatGPT maker OpenAI was awarded a $200 million contract to provide the U.S. Defense Department with artificial intelligence tools, the Pentagon said in a statement on Monday.

Micron Technology plans to invest more than $200 billion in semiconductor manufacturing in the U.S., a move it estimates will create roughly 90,000 direct and indirect jobs.

Chipmaker Micron Technology Inc. said it will spend about $200 billion on US manufacturing, research and development, the latest company to pledge large-scale investments in the country since ...